EMEA-002010-PIP01-16-M03

Key facts

Invented name
Yescarta
Active substance
Axicabtagene ciloleucel
Therapeutic area
Oncology
Decision number
P/0114/2022
PIP number
EMEA-002010-PIP01-16-M03
Pharmaceutical form(s)
Dispersion for infusion
Condition(s) / indication(s)
Treatment of mature B-cell neoplasms
Route(s) of administration
Intravenous use
Contact for public enquiries
Kite Pharma EU B.V.

Tel. +1 4242091332
E-mail: regulatory@kitepharma.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

Related content

How useful was this page?

Add your rating